Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
September 30, 2026 -11.88M
June 30, 2026 -25.06M
March 31, 2026 28.88M
December 31, 2025 -21.97M
September 30, 2025 -43.26M
June 30, 2025 -50.11M
March 31, 2025 -53.36M
December 31, 2024 -44.59M
September 30, 2024 -46.48M
June 30, 2024 16.19M
March 31, 2024 -73.05M
December 31, 2023 -49.78M
September 30, 2023 9.623M
June 30, 2023 -45.59M
March 31, 2023 -47.46M
December 31, 2022 -7.775M
September 30, 2022 -27.03M
June 30, 2022 -33.40M
March 31, 2022 -37.42M
December 31, 2021 -23.66M
September 30, 2021 110.26M
June 30, 2021 36.62M
March 31, 2021 -33.67M
December 31, 2020 -20.24M
September 30, 2020 -21.95M
Date Value
June 30, 2020 -18.69M
March 31, 2020 -23.17M
December 31, 2019 -14.36M
September 30, 2019 -8.654M
June 30, 2019 -11.95M
March 31, 2019 -17.44M
December 31, 2018 -20.50M
September 30, 2018 -33.00M
June 30, 2018 57.73M
March 31, 2018 -31.58M
December 31, 2017 -39.62M
September 30, 2017 -22.16M
June 30, 2017 -37.31M
March 31, 2017 -37.84M
December 31, 2016 -30.75M
September 30, 2016 -30.19M
June 30, 2016 -28.16M
March 31, 2016 -25.15M
December 31, 2015 -19.38M
September 30, 2015 -16.61M
June 30, 2015 -10.93M
March 31, 2015 -14.72M
December 31, 2014 -12.21M
September 30, 2014 -12.55M
June 30, 2014 6.220M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Alkermes Plc 93.48M
Amarin Corp. Plc 9.218M
Agenus, Inc. -20.10M
Amgen, Inc. 4.241B
Anika Therapeutics, Inc. 8.377M